Ediz E. Dalkilic

Bursa, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study.

Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study.

Journal: Scandinavian journal of rheumatology

Published: August 20, 2026

Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.

Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.

Journal: EULAR rheumatology open

Published: June 29, 2026

Association of rheumatoid factor with vasculitic manifestations and distinct clinical patterns in eosinophilic granulomatosis with polyangiitis: a multicenter observational study.

Association of rheumatoid factor with vasculitic manifestations and distinct clinical patterns in eosinophilic granulomatosis with polyangiitis: a multicenter observational study.

Journal: Rheumatology international

Published: May 02, 2026

Clinical and serological predictors of autoimmune etiology in patients with interstitial lung disease: a 10-year retrospective study.

Clinical and serological predictors of autoimmune etiology in patients with interstitial lung disease: a 10-year retrospective study.

Journal: Clinical rheumatology

Published: April 27, 2026

The Effect of Adding Paraffin Bath to the Therapeutic Hand Exercise Programme on Hand Functions in Patients with Systemic Sclerosis: A Randomized, Controlled, Single-Blind Study.

The Effect of Adding Paraffin Bath to the Therapeutic Hand Exercise Programme on Hand Functions in Patients with Systemic Sclerosis: A Randomized, Controlled, Single-Blind Study.

Journal: Archives of rheumatology

Published: February 23, 2026

Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?

Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases?

Journal: Journal of clinical medicine

Published: July 14, 2025

Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience.

Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience.

Journal: Journal of clinical medicine

Published: June 25, 2025

Can M-score be used to predict recurrence in IGM patients?

Can M-score be used to predict recurrence in IGM patients?

Journal: European journal of medical research

Published: June 09, 2025

Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study.

Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study.

Journal: Seminars in arthritis and rheumatism

Published: April 20, 2025

Patients Diagnosed with Granulomatosis with Polyangiitis: The Journey to Receive Rheumatologist Care.

Patients Diagnosed with Granulomatosis with Polyangiitis: The Journey to Receive Rheumatologist Care.

Journal: Journal of clinical medicine

Published: April 15, 2025

Efficacy and Safety of Anakinra in Colchicine-Resistant or -Intolerant Familial Mediterranean Fever: A Single-Center Real-Life Experience.

Efficacy and Safety of Anakinra in Colchicine-Resistant or -Intolerant Familial Mediterranean Fever: A Single-Center Real-Life Experience.

Journal: Medicina (Kaunas, Lithuania)

Published: February 20, 2025

Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective study.

Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective study.

Journal: Clinical rheumatology

Published: December 03, 2024

Showing 1-12 of 89

Last Updated: 09/26/2026